M. KAUR and S. MISRA, “REMTERNETUG: AN INVESTIGATIONAL MONOCLONAL ANTIBODY AGAINST Β-AMYLOID FOR THE TREATMENT OF ALZHEIMER’S DISEASE (AD)”, Int J Curr Pharm Sci, vol. 17, no. 3, pp. 7–9, May 2025.